Kim Le, FNP-C

NPI: 1609271709
Total Payments
$1,266
2024 Payments
$279.90
Companies
2
Transactions
62
Medicare Patients
3,188
Medicare Billing
$84,671

Payment Breakdown by Category

Food & Beverage$1,243 (98.2%)
Education$23.39 (1.8%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,243 59 98.2%
Education $23.39 3 1.8%

Top Paying Companies

Company Total Records Latest Year
ACADIA Pharmaceuticals Inc $1,156 61 $0 (2024)
Novo Nordisk Inc $109.98 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $279.90 18 ACADIA Pharmaceuticals Inc ($279.90)
2023 $720.21 28 ACADIA Pharmaceuticals Inc ($720.21)
2022 $243.74 15 ACADIA Pharmaceuticals Inc ($133.76)
2021 $22.37 1 ACADIA Pharmaceuticals Inc ($22.37)

All Payment Transactions

62 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/20/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $7.66 General
Category: PARKINSONS DISEASE PSYCHOSIS
10/22/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $6.90 General
Category: PARKINSONS DISEASE PSYCHOSIS
09/20/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $11.36 General
Category: PARKINSONS DISEASE PSYCHOSIS
09/12/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $12.56 General
Category: PARKINSONS DISEASE PSYCHOSIS
08/16/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $113.84 General
Category: PARKINSONS DISEASE PSYCHOSIS
08/07/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $11.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
07/25/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $8.14 General
Category: PARKINSONS DISEASE PSYCHOSIS
07/10/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $20.53 General
Category: PARKINSONS DISEASE PSYCHOSIS
06/30/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $13.59 General
Category: PARKINSONS DISEASE PSYCHOSIS
05/16/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $7.09 General
Category: PARKINSONS DISEASE PSYCHOSIS
05/10/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $5.57 General
Category: PARKINSONS DISEASE PSYCHOSIS
04/11/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $10.21 General
Category: PARKINSONS DISEASE PSYCHOSIS
04/10/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $6.13 General
Category: PARKINSONS DISEASE PSYCHOSIS
03/27/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $11.01 General
Category: PARKINSONS DISEASE PSYCHOSIS
03/27/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $1.70 General
Category: PARKINSONS DISEASE PSYCHOSIS
03/20/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $14.02 General
Category: PARKINSONS DISEASE PSYCHOSIS
02/02/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $12.74 General
Category: PARKINSONS DISEASE PSYCHOSIS
01/22/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $5.85 General
Category: PARKINSONS DISEASE PSYCHOSIS
12/19/2023 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $13.86 General
Category: PARKINSONS DISEASE PSYCHOSIS
12/11/2023 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $14.14 General
Category: PARKINSONS DISEASE PSYCHOSIS
11/28/2023 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $11.24 General
Category: PARKINSONS DISEASE PSYCHOSIS
11/15/2023 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $7.51 General
Category: PARKINSONS DISEASE PSYCHOSIS
11/07/2023 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $113.03 General
Category: PARKINSONS DISEASE PSYCHOSIS
11/07/2023 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $113.03 General
Category: PARKINSONS DISEASE PSYCHOSIS
10/25/2023 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $13.53 General
Category: PARKINSONS DISEASE PSYCHOSIS

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 13 1,197 2,640 $136,837 $30,652
2022 9 1,088 2,264 $107,097 $21,816
2021 12 685 862 $91,701 $20,058
2020 6 218 268 $44,672 $12,144
Total Patients
3,188
Total Services
6,034
Medicare Billing
$84,671
Procedure Codes
40

All Medicare Procedures & Services

40 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
93793 Anticoagulant management of patient taking warfarin Office 2023 573 1,772 $53,160 $11,306 21.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 118 182 $37,907 $8,820 23.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 24 24 $7,124 $1,895 26.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 38 39 $6,011 $1,787 29.7%
G0250 Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent Office 2023 215 347 $8,675 $1,780 20.5%
36415 Insertion of needle into vein for collection of blood sample Office 2023 71 118 $1,770 $991.20 56.0%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2023 13 13 $1,366 $985.53 72.1%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 17 17 $3,239 $787.39 24.3%
87811 Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) Office 2023 17 17 $850.00 $689.35 81.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 53 53 $14,575 $684.80 4.7%
G0008 Administration of influenza virus vaccine Office 2023 16 16 $760.00 $473.70 62.3%
G0444 Annual depression screening, 5 to 15 minutes Office 2023 28 28 $1,260 $420.56 33.4%
81003 Automated urinalysis test Office 2023 14 14 $140.00 $30.80 22.0%
93793 Anticoagulant management of patient taking warfarin Office 2022 548 1,494 $44,820 $9,651 21.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 88 146 $30,195 $6,122 20.3%
G0250 Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent Office 2022 243 373 $9,325 $1,746 18.7%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2022 18 19 $2,090 $1,327 63.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 20 20 $3,182 $907.58 28.5%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 49 49 $13,475 $723.01 5.4%
G0008 Administration of influenza virus vaccine Office 2022 18 19 $950.00 $544.37 57.3%
G0444 Annual depression screening, 15 minutes Office 2022 30 30 $1,350 $459.04 34.0%
36415 Insertion of needle into vein for collection of blood sample Office 2022 74 114 $1,710 $336.63 19.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 145 214 $43,416 $9,726 22.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 60 60 $16,500 $2,359 14.3%
93793 Anti-clotting management for patient taking warfarin Office 2021 199 260 $7,800 $2,004 25.7%

About Kim Le, FNP-C

Kim Le, FNP-C is a Nurse Practitioner healthcare provider based in Topeka, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2014. The National Provider Identifier (NPI) number assigned to this provider is 1609271709.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kim Le, FNP-C has received a total of $1,266 in payments from pharmaceutical and medical device companies, with $279.90 received in 2024. These payments were reported across 62 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($1,243).

As a Medicare-enrolled provider, Le has provided services to 3,188 Medicare beneficiaries, totaling 6,034 services with total Medicare billing of $84,671. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Other Specialties Family
  • Location Topeka, KS
  • Active Since 10/31/2014
  • Last Updated 02/12/2025
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • NPI Number 1609271709

Products in Payments

  • NUPLAZID (Drug) $1,156
  • Rybelsus (Drug) $109.98

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Topeka